MCAS supportive care, quality of life, and managing side effects

Supportive care is a key part of long-term MCAS treatment. It focuses on improving day-to-day well-being, addressing symptoms, managing side effects, and reducing triggers contributing to flares.25 This often requires an individually tailored approach, which may involve specialists, general practitioners, and allied health professionals.

Different aspects of quality of life carry varying levels of importance for each individual.²⁸ Where appropriate, and when adjustments do not compromise safety or overall treatment outcomes, patients are encouraged to advocate for their personal well-being goals during specialist reviews. For some, this may include seeking to avoid medications that cause excessive sedation due to their impact on work or daily functioning. Others may prioritise avoiding treatments that affect confidence or comfort in social situations, such as those associated with hair thinning or weight changes.

Conversely, some patients may be willing to utilise specific therapies alongside supportive strategies to reduce or manage side effects.^28,29 This may include medications to counter sedation, address nausea, or access to allied health supports that help maintain function and independence. In some cases, physiotherapy, occupational therapy, or psychological support may also be helpful, particularly when symptoms impact mobility, cognitive function, or emotional well-being.

As MCAS symptoms may also overlap with the presentation of treatment side effects, patients are encouraged to discuss possible side effects and quality of life concerns with their treating specialist and general practitioner throughout their care.²⁹ Prompt reporting and candid discussion about the impact of new or worsening symptoms can support timely investigations, reduce potential risks, and allow for adaptive supportive care strategies to maintain or improve quality of life as patients’ goals and needs evolve.

Paediatric MCAS

While confirmed cases of MCAS are rare in children, documented instances do exist. Supportive care for paediatric MCAS typically includes treatments with common medications to control generally mild symptoms, such as itch or gastrointestinal issues. However, as Secondary MCAS is the most prevalently documented paediatric subtype, often occurring as a response to underlying allergic or inflammatory conditions, some children may require adrenaline autoinjectors and dietary adjustments in addition to standard medications.^3,30

For children who carry adrenaline autoinjectors, supportive care should include age-appropriate education on their safe use, as well as clear language to seek help from adults during an emergency.³¹ Families and school staff should know how to recognise symptoms of anaphylaxis and respond effectively.³¹ Empowering children with a sense of confidence and understanding around their condition can help reduce anxiety and improve overall safety.

While dietary changes may be necessary for allergies or other inflammatory conditions, no specific dietary guidelines exist for MCAS. Families who consider dietary changes are strongly encouraged to engage with a registered dietitian. Professional guidance helps maintain nutritional adequacy and may reduce the risk of food aversions or fears through appropriate education and supportive language. Dietitians can also advise on setting realistic timeframes for elimination trials and safe reintroduction, preventing unnecessary long-term restrictions.²

MCAS diagnostics processes can be complicated and drawn out, with frequent delays in diagnosis, particularly in paediatric cases. As such, both children with symptoms who have suspected MCAS, and those with confirmed MCAS may benefit from play therapy and psychological support.^32,33 These interventions can help children process their experiences, build coping skills, and maintain engagement in age-appropriate activities, even when adjustments are necessary due to symptom management.^32,33 Early psychological support may also alleviate anxiety related to medical care and reduce long-term emotional impacts.

Pre-teens and adolescents, particularly those with known allergens, should also receive formalised education on drug and alcohol safety to reduce the risk of severe reactions. This includes understanding potential cross-reactivity, the dangers of unmonitored substances, and recognising symptoms of an allergic or mast cell-related reaction. More information on these issues can be found at Allergy 250K YA.

Adult MCAS

Supportive care approaches for adult patients with mast cell activation syndrome (MCAS) can vary significantly depending on the diagnosed subtype. The three clinically recognised subtypes in Australia and Aotearoa New Zealand are Primary MCAS, Secondary MCAS, and Idiopathic MCAS.² Each subtype presents unique challenges and may require specific management strategies to control symptoms, reduce triggers, and improve quality of life.⁷

• Primary MCAS often aligns closely with supportive care strategies seen in non-advanced mastocytosis. Management typically involves standard medications, such as antihistamines, mast cell stabilisers, and leukotriene receptor antagonists, along with regular monitoring to manage symptoms and prevent progression. Supportive care also includes lifestyle modifications and environmental adjustments to reduce known triggers.^1,7,34 Read about supportive care for non-Adv SM.
• Secondary MCAS occurs in response to underlying allergic or inflammatory conditions. Effective supportive care requires additional focussed care to address the primary health issue driving mast cell activation. This may include targeted therapies for the underlying condition, dietary adjustments if food-related triggers are identified, and collaborative care with allergy, immunology, or rheumatology specialists.^1,7,35
• Idiopathic MCAS is diagnosed when there is mast cell activation without an identifiable trigger or underlying condition. Supportive care focuses primarily on symptom control and lifestyle adjustments. Due to the unpredictability of reactions, care often includes environmental modifications and personalised symptom tracking to identify potential triggers. Strategies may include avoidance of known triggers, gradual introduction of dietary elements, and regular assessment of symptom patterns to adapt management plans effectively.^1,7,36

An adult diagnosis of MCAS often represents either the sudden onset of symptoms or a diagnosis following a prolonged period of uncertainty. For many patients, this journey can be psychologically challenging. As such, regardless of subtype, psychiatric and psychological support can play a critical role in helping individuals adjust to their diagnosis and its implications, and to build new coping skills, reducing anxiety, and improving overall quality of life.³⁷

While a tentative or suspected diagnosis can bring relief, patients must understand their specific subtype to establish tailored supportive care. Personalised care allows for more effective symptom management, better identification of potential triggers, and adjustments to lifestyle or medication that can significantly improve well-being and daily functioning.³⁴